Drug therapy for vertebral fractures in osteoporosis: evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacy.

[1]  H W Wahner,et al.  Changes in bone mineral density of the proximal femur and spine with aging. Differences between the postmenopausal and senile osteoporosis syndromes. , 1982, The Journal of clinical investigation.

[2]  A. Lane,et al.  Treatment of Postmenopausal Osteoporosis with Transdermal Estrogen , 1992, Annals of Internal Medicine.

[3]  J. Reisch,et al.  Slow-Release Sodium Fluoride in the Management of Postmenopausal Osteoporosis , 1994, Annals of Internal Medicine.

[4]  H. Genant,et al.  Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. , 1990, The New England journal of medicine.

[5]  L. Mosekilde,et al.  Marked decrease in trabecular bone quality after five years of sodium fluoride therapy--assessed by biomechanical testing of iliac crest bone biopsies in osteoporotic patients. , 1994, Bone.

[6]  Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. , 1990, The New England journal of medicine.

[7]  L. Melton,et al.  The prevention and treatment of osteoporosis. , 1992, The New England journal of medicine.

[8]  K. Mann,et al.  Increase in serum bone gamma-carboxyglutamic acid protein with aging in women. Implications for the mechanism of age-related bone loss. , 1983, The Journal of clinical investigation.

[9]  David W. Bates,et al.  CLINICAL USE OF BONE DENSITOMETRY , 1991 .

[10]  W M O'Fallon,et al.  Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. , 1990, The New England journal of medicine.

[11]  A. Prost,et al.  RISK-BENEFIT RATIO OF SODIUM FLUORIDE TREATMENT IN PRIMARY VERTEBRAL OSTEOPOROSIS , 1988, The Lancet.

[12]  B. Riggs,et al.  The Effect of Calcitriol on Patients with Postmenopausal Osteoporosis with Special Reference to Fracture Frequency , 1989, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[13]  M. Kleerekoper,et al.  Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss. , 1983, The Journal of clinical investigation.

[14]  W. O'Fallon,et al.  Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy. , 1982, The New England journal of medicine.

[15]  P. Ruegsegger,et al.  Long-term fluoride therapy of postmenopausal osteoporosis. , 1986, Bone.

[16]  L. Melton,et al.  Clinical trial of fluoride therapy in postmenopausal osteoporotic women: Extended observations and additional analysis , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.